Injury to the Ca2+ ATPase of the sarcoplasmic reticulum in anesthetized dogs contributes to myocardial reperfusion injury

Cardiovascular Research

Volumn 36, Issue 2, 1997, Pages 174-184

  Smart, Steven C ^a   Sagar, Kiran B ^a   Schultz, Jo El ^a   Warltier, David C ^a   Jones, Larry R ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anesthetized; Calcium; Calcium channel antagonist; Dog; Intracellular concentration; Myocardial ischemia; Nifedipine; Protein analysis; Reperfusion; Stunning arrhythmias; Ventricular fibrillation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL BLOCKING AGENT; CALSEQUESTRIN; NIFEDIPINE; PHOSPHOLAMBAN; RYANODINE; CALCIUM; CALCIUM BINDING PROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART MUSCLE PERFUSION; HEMODYNAMICS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; REPERFUSION INJURY; SARCOPLASMIC RETICULUM; ANIMAL; DOG; DRUG EFFECT; ENZYMOLOGY; HEART CONTRACTION; IMMUNOBLOTTING; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; PERFUSION;

ANIMALS; ANTIBODIES, MONOCLONAL; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; DOGS; IMMUNOBLOTTING; MEMBRANE PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; NIFEDIPINE; PERFUSION; RYANODINE; SARCOPLASMIC RETICULUM;

EID: 0031260637     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00175-2     Document Type: Article

References (50)

1. Opie L.H. Reperfusion injury and its pharmacologic modification. Circulation. 80:1989;1049-1062.
2. Bolli R. Mechanism of myocardial "stunning" Circulation. 82:1990;723-738.
3. Kloner R.A., Przyklenk K., Patel B. Altered myocardial sites. The stunned and hibernating myocardium. Am J Med. 86:1989;14-22.
4. 2+ overload in reperfused ischemic myocardium. Ann Rev Physiol. 52:1990;543-559.
5. Schaper W, Ito B. The energetics of "stunned myocardium". In: De Jong JW, ed. Myocardial Energy Metabolism. Dordrecht: Martinus Nijhoff Publishing, 1988:203-213.
6. Braunwald E., Kloner R.A. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 66:1982;1146-1149.
7. Mubagwa K. Sarcoplasmic reticulum function during myocardial ischemia and reperfusion. Cardiovasc Res. 30:1995;166-175.
8. 2+ influx in myocardial cells by beta adrenergic receptors, cyclic nucleotides, and phosphorylation. Mol Cell Biochem. 82:1988;19-28.
9. Opie L.H. Myocardial stunning-are calcium antagonists useful? Cardiovasc Drug Ther. 8:1994;533-541.
10. Opie L.H., du Toit E.F. Postischemic stunning: the two-phase model for the role of calcium as pathogen. J Cardiovasc Pharmacol. 20:1992;S1-4.
11. Barry W.H., Bridge J.H.B. Intracellular calcium homeostasis in cardiac myocytes. Circulation. 87:1993;1806-1815.
12. du Toit E.F., Opie L.H. Modulation of the severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at the onset of reperfusion. Circ Res. 70:1992;960-967.
13. 2+ exchange in myocardial reperfusion injury in open chest dogs: relative roles during ischemia and reperfusion. Cardiovasc Res 1997. (in press).
14. Theroux P., Franklin D., Ross J. jr., Kemper W.S. Regional myocardial function during acute coronary occlusion and its modification by pharmacologic agents in the dog. Circ Res. 35:1974;896-908.
15. Domenech R., Hoffman J., Noble M., Saunders K., Henson J., Subijanto S. Total and regional coronary blood flow measured by radioactive microspheres in conscious and anesthetized dogs. Circulation. 25:1969;581-596.
16. Bolli R., Zhu W., Thornby J.I., O'Neill P.G., Roberts R. Time course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol. 254:1988;H102-H114.
17. 2+ channels. J Am Coll Cardiol. 26:1995;1365-1373.
18. 2+ transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 90:1994;653-657.
19. Jones L.R., Cala S.E. Biochemical evidence for functional heterogeneity of cardiac sarcoplasmic reticulum vesicles. J Biol Chem. 256:1981;11809-11818.
20. Lowry D.H., Rosenborough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
21. 2+ uptake in mammalian ventricular myocytes. Am J Physiol. 261:1991;H1344-H1349.
22. 2+ transport ATPase of cardiac sarcoplasmic reticulum. J Biol Chem. 268:1993;11486-11488.
23. 2+ uptake by cardiac sarcoplasmic reticulum vesicles. J Pharmacol Exp Ther. 209:1979;48-55.
24. Porzio M.A., Person A.M. Improved resolution of myofibrillar proteins with sodium dodecyl sulfate A-polyacrylamide gel electrophoresis. Biochim Biophys Acta. 490:1977;27-34.
25. Rardon D.P., Cefali D.C., Mitchell R.D., Seiler S.M., Hathaway D.R., Jones L.R. Digestion of cardiac and skeletal muscle junctional sarcoplasmic reticulum vesicles with calpain II. Circ Res. 67:1990;84-96.
26. Thandroyen F.T., McCarthy J., Burton K.B., Opie L.H. Ryanodine and caffeine prevent ventricular arrhythmias during acute myocardial ischemia and reperfusion in rat hearts. Circ Res. 62:1988;306-314.
27. du Toit E.F., Opie L.H. Antiarrhythmic properties of specific inhibitors of sarcoplasmic reticulum calcium ATPase in the isolated rat heart after coronary artery ligation. J Am Coll Cardiol. 76:1994;1505-1510.
28. Lamping K.A., Gross G.J. Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine. J Cardiovasc Pharmacol. 7:1985;158-166.
29. Przyklenk K., Kloner R.A. Effect of verapamil on postischemic "stunned" myocardium: Importance of the timing of treatment. J Am Coll Cardiol. 11:1988;614-623.
30. Przyklenk K., Ghafari G.B., Eitzman D.T., Kloner R.A. Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic "stunned" myocardium. J Am Coll Cardiol. 13:1989;1176-1183.
31. Ferrari R., Albertini A., Curello S., Ceconi C., Di Lisa F., Raddino R., Vistoli O. Myocardial recovery during post-ischaemic reperfusion: Effects of nifedipine, calcium, and magnesium. J Mol Cell Cardiol. 18:1986;487-498.
32. Watts J.A., Maiorano L.J., Maiorano P.C. Protection by verapamil of globally ischemic rat hearts: energy preservation, a partial explanation. J Mol Cell Cardiol. 17:1985;797-804.
33. Watts J.A., Maiorano L.J., Maiorano P.C. Comparison of the protective effects of verapamil, diltiazem, nifedipine, and buffer containing low calcium upon global myocardial ischemic injury. J Mol Cell Cardiol. 18:1986;255-263.
34. Henry P.D. Comparative pharmacology of calcium antagonists: nifedipine, verapamil, and diltiazem. Am J Cardiol. 46:1980;1047-1058.
35. Kleyman T.R., Cragoe E.J. Jr. Amiloride and its analogs as tools in the study of ion transport. J Membrane Biol. 105:1988;1-21.
36. Yoshida Y., Shiga T., Imai S. Degradation of sarcoplasmic reticulum calcium pumping ATPase in ischemic-reperfused myocardium: Role of calcium-activated neutral protease. Basic Res Cardiol. 85:1990;495-507.
37. 2+ channels. Circ Res. 74:1994;271-280.
38. Dhalla N.S., Panagia V., Singal P.K., Makino N., Dixon I.M.C., Eyolfson D.A. Alterations in heart membrane calcium transport during the development of ischemia-reperfusion injury. J Mol Cell Cardiol. 20(II):1988;3-13.
39. 2+ uptake by sarcoplasmic reticulum after coronary artery occlusion for 60 and 90 minutes. Circ Res. 21:1967;439-444.
40. Fukumoto K., Takenaka H., Onitsuka T., Koga Y., Hamada M. Effects of hypothermic ischemia and reperfusion on calcium transport by myocardial sarcolemma and sarcoplasmic reticulum. J Mol Cell Cardiol. 23:1991;525-535.
41. Limbruno U., Zucchi R., Ronca-Testoni S., Galbani P., Ronca G., Mariano M. Sarcoplasmic reticulum function in the "stunned" myocardium. J Mol Cell Cardiol. 21:1989;1063-1072.
42. Kaplan P., Hendrickx ?, Mattheussen M., Mubagwa K., Flameng W. Effect of ischemia and reperfusion on sarcoplasmic reticulum calcium uptake. Circ Res. 71:1992;1123-1130.
43. Feher J.J., LeBolt W.R., Manson N.H. Differential effects of global ischemia on the ryanodine-sensitive and ryanodine-insensitive calcium uptake of the cardiac sarcoplasmic reticulum. Circ Res. 65:1989;1400-1408.
44. Davis M.D., LeBolt W., Feher J.J. Reversibility of the effects of normothermic global ischemia on the ryanodine-sensitive and ryanodine-insensitive calcium transport of the cardiac sarcoplasmic reticulum. Circ Res. 70:1992;163-171.
45. 2+ transport. Circulation. 84:1991;1378-1383.
46. Krause S.M., Jacobus W.E., Becker L.C. Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischemic "stunned" myocardium. Circ Res. 65:1989;526-530.
47. Balke C.W., Kaplinsky E., Michelson E.L., Naito M., Dreifus L.S. Reperfusion ventricular tachyarrhythmias: Correlation with antecedent coronary occlusion tachyarrhythmias and duration of myocardial ischemia. Am Heart J. 101:1981;449-456.
48. Feher J.J., Briggs F.N., Hess M.L. Characterization of cardiac sarcoplasmic reticulum from ischemic myocardium: Comparison of isolated sarcoplasmic reticulum with unfractionated homogenates. J Mol Cell Cardiol. 12:1980;427-432.
49. 2+ exchange. Euro J Pharm. 105:1984;317-322.
50. Krause S., Hess M.L. Characterization of cardiac sarcoplasmic reticulum dysfunction during short-term, normothermic, global ischemia. Circ Res. 55:1984;176-184.